| Index | — | P/E | 7.11 | EPS (ttm) | 3.61 | Insider Own | — | Shs Outstand | 705.57M | Perf Week | -4.39% |
| Market Cap | 18.11B | Forward P/E | 14.43 | EPS next Y | 1.78 | Insider Trans | -0.00% | Shs Float | 463.18M | Perf Month | 8.08% |
| Enterprise Value | 25.69B | PEG | 0.73 | EPS next Q | 0.41 | Short Float | 3.84% | Perf Quarter | 9.00% | ||
| Income | 2.77B | P/S | 0.35 | EPS this Y | -4.13% | Short Ratio | 6.97 | Perf Half Y | 13.33% | ||
| Sales | 52.22B | P/B | 1.27 | EPS next Y | 11.56% | ROA | 9.46% | Short Interest | 17.80M | Perf YTD | 42.93% |
| Book/sh | 20.25 | P/C | 17.10 | EPS next 5Y | 9.71% | ROE | 27.46% | 52W High | 26.98 -4.86% | Perf Year | 50.91% |
| Cash/sh | 1.50 | P/FCF | 7.63 | EPS past 3/5Y | 11.73% — | ROIC | 5.97% | 52W Low | 16.00 60.44% | Perf 3Y | 67.45% |
| Dividend Est. | 1.67 (6.51%) | EV/EBITDA | 8.34 | Sales past 3/5Y | -8.27% 13.70% | Gross Margin | 4.49% | Volatility | 1.69% 1.79% | Perf 5Y | 136.59% |
| Dividend TTM | 1.67 (6.51%) | EV/Sales | 0.49 | EPS Y/Y TTM | 299.73% | Oper. Margin | 2.87% | ATR (14) | 0.52 | Perf 10Y | -20.89% |
| Dividend Ex-Date | Oct 30, 2026 | Quick Ratio | 1.10 | Sales Y/Y TTM | 9.25% | Profit Margin | 5.30% | RSI (14) | 51.62 | Recom | 2.43 |
| Dividend Gr. 3/5Y | 22.15% 11.05% | Current Ratio | 1.12 | EPS Q/Q | 13.89% | SMA20 | 0.70% | Beta | 0.56 | Target Price | 27.10 |
| Payout | 48.35% | Debt/Eq | 0.60 | Sales Q/Q | 66.26% | SMA50 | 1.65% | Rel Volume | 1.78 | Prev Close | 26.51 |
| Employees | 3,900 | LT Debt/Eq | 0.60 | Earnings | Nov 06 | SMA200 | 12.27% | Avg Volume | 2.58M | Price | 25.67 |
| IPO Date | Nov 18, 1998 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 7.45% 39.05% | Net Debt/EBITDA | 2.46 | Volume | 4,578,191 | Change | -3.17% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-19-26 | Reiterated | Raymond James | Strong Buy | $27 → $28 |
| Oct-15-26 | Reiterated | Scotiabank | Sector Outperform | $27 → $28 |
| Oct-09-26 | Initiated | Jefferies | Buy | $27 |
| Oct-09-26 | Reiterated | UBS | Buy | $28 → $31 |
| Sep-21-26 | Reiterated | Raymond James | Strong Buy | $22 → $27 |
| Sep-21-26 | Reiterated | UBS | Buy | $25 → $28 |
| Sep-21-26 | Reiterated | Barclays | Underweight | $23 → $24 |
| Sep-21-26 | Reiterated | Mizuho | Outperform | $27 → $30 |
| Sep-10-26 | Reiterated | Scotiabank | Sector Outperform | $24 → $27 |
| Aug-18-26 | Reiterated | Morgan Stanley | Equal Weight | $25 → $26 |
Plains All American Pipeline, L.P., through its subsidiaries, engages in the pipeline transportation, terminalling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, trucks, and on barges or railcars. This segment provides terminalling, storage, and other related services, as well as merchant activities. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminaling. This segment also includes ethane, propane, normal butane, iso-butane, and natural gasoline derived from natural gas production and processing activities, as well as crude oil refining processes. Its NGL components are used for various applications, such as heating, engine, and industrial fuels.The company was founded in 1981 and is headquartered in Houston, Texas. Plains All American Pipeline, L.P. operates as a subsidiary of Plains GP Holdings, L.P.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 52,217 | 44,262 | 50,073 | 48,712 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 49,875 | 41,587 | 48,354 | 45,956 | — | — | — | — | — | |
| Gross Profit | 2,342 | 2,675 | 1,719 | 2,756 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 372 | 342 | 381 | 350 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 469 | 899 | 160 | 896 | — | — | — | — | — | |
| Operating Income | 1,501 | 1,434 | 1,178 | 1,510 | — | — | — | — | — | |
| Interest Expense | 614 | 554 | 430 | 386 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 606 | 521 | 532 | 499 | — | — | — | — | — | |
| Net Income Before Taxes | 1,493 | 1,401 | 1,280 | 1,623 | — | — | — | — | — | |
| Income Taxes | 105 | 15 | 167 | 121 | — | — | — | — | — | |
| Consolidated Net Income | 2,765 | 1,435 | 772 | 1,230 | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,388 | 1,386 | 1,113 | 1,502 | — | — | — | — | — | |
| Net Income | 2,765 | 1,435 | 772 | 1,230 | — | — | — | — | — | |
| EPS (Recurring) | 3.61 | 1.66 | 0.73 | 1.40 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.61 | 1.66 | 0.73 | 1.40 | — | — | — | — | — | |
| EPS (Diluted) | 3.61 | 1.66 | 0.73 | 1.40 | — | — | — | — | — | |
| EBITDA | 3,080 | 2,908 | 2,736 | 3,057 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 7.11 | 10.82 | 23.40 | 10.82 | — | — | — | — | — | |
| Price To Sales Ratio | 0.35 | 0.29 | 0.24 | 0.22 | — | — | — | — | — | |
| Gross Margin | 4.49 | 6.04 | 3.43 | 5.66 | — | — | — | — | — | |
| Operating Margin | 2.87 | 3.24 | 2.35 | 3.10 | — | — | — | — | — | |
| Net Margin | 5.30 | 3.24 | 1.54 | 2.53 | — | — | — | — | — | |
| Shares Outstanding | 706 | 704 | 702 | 699 | — | — | — | — | — | |
| Market Capitalization | 18,123 | 12,644 | 11,990 | 10,590 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Chiang Willie CW | Chairman & CEO | Aug 14 '26 | Option Exercise | 0.00 | 346,357 | 0 | 1,533,148 | Aug 17 |
| McGee Richard K. | EVP, General Counsel & Sec. | Aug 14 '26 | Option Exercise | 0.00 | 109,165 | 0 | 715,518 | Aug 17 |
| Herbold Chris | Sr. VP Finance & CAO | Aug 14 '26 | Option Exercise | 0.00 | 140,609 | 0 | 381,682 | Aug 17 |
| Goebel Jeremy L. | EVP & CCO | Aug 14 '26 | Option Exercise | 0.00 | 640,691 | 0 | 640,691 | Aug 17 |
| Chandler Chris R. | EVP & COO | Aug 14 '26 | Option Exercise | 0.00 | 640,691 | 0 | 1,134,595 | Aug 17 |
| Swanson Al | EVP & CFO | Aug 14 '26 | Option Exercise | 0.00 | 109,165 | 0 | 711,066 | Aug 17 |
| Ziemba Lawrence Michael | Director | Jun 29 '26 | Sale | 21.95 | 2,346 | 51,495 | 0 | Jun 30 |
| Herbold Chris | Sr. VP Finance & CAO | Aug 14 '25 | Option Exercise | 0.00 | 65,796 | 0 | 264,357 | Aug 18 |
| Goebel Jeremy L. | EVP & CCO | Aug 14 '25 | Option Exercise | 0.00 | 227,864 | 0 | 227,864 | Aug 18 |
| Chandler Chris R. | EVP & COO | Aug 14 '25 | Option Exercise | 0.00 | 227,864 | 0 | 583,569 | Aug 18 |
| Chiang Willie CW | Chairman & CEO | Aug 14 '25 | Option Exercise | 0.00 | 561,055 | 0 | 1,407,567 | Aug 18 |
| Swanson Al | EVP & CFO | Aug 14 '25 | Option Exercise | 0.00 | 176,731 | 0 | 671,445 | Aug 18 |
| McGee Richard K. | EVP, General Counsel & Sec. | Aug 14 '25 | Option Exercise | 0.00 | 176,731 | 0 | 675,897 | Aug 18 |
| Swanson Al | EVP & CFO | Aug 14 '24 | Option Exercise | 0.00 | 167,378 | 0 | 560,578 | Aug 16 |
| Goebel Jeremy L. | EVP & CCO | Aug 14 '24 | Option Exercise | 0.00 | 167,378 | 0 | 167,378 | Aug 16 |